We are live on ! Find out more
MGNX icon

MacroGenics

154 hedge funds and large institutions have $1.21B invested in MacroGenics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 59 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

390% more call options, than puts

Call options by funds: $11.8M | Put options by funds: $2.4M

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

3% more funds holding

Funds holding: 149154 (+5)

0.56% less ownership

Funds ownership: 95.28%94.72% (-0.56%)

21% less capital invested

Capital invested by funds: $1.53B → $1.21B (-$318M)

27% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 59

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
154
Holders Change
+5
Holders Change %
+3.36%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
18
Increased
43
Reduced
59
Closed
13
Calls
$11.8M
Puts
$2.4M
Net Calls
+$9.36M
Net Calls Change
+$6.04M
Name Holding Trade Value Shares
Change
Change in
Stake
PA
26
Pinnacle Associates
New York
$8.72M -$138K -5,735 -1%
ABG
27
Ally Bridge Group
New York
$7.64M +$6.07M +252,161 +223%
N
28
Nuveen
North Carolina
$7.37M -$595K -24,716 -7%
Goldman Sachs
29
Goldman Sachs
New York
$6.52M +$2.11M +87,487 +39%
Lord, Abbett & Co
30
Lord, Abbett & Co
New Jersey
$5.89M -$88.5K -3,674 -1%
Principal Financial Group
31
Principal Financial Group
Iowa
$5.38M +$183K +7,582 +3%
GIM
32
Granahan Investment Management
Massachusetts
$4.84M -$684K -28,384 -11%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$4.13M +$530K +22,018 +13%
IC
34
Ikarian Capital
Texas
$3.95M -$6.53M -271,124 -59%
IHAM
35
Integral Health Asset Management
New York
$3.35M +$3.85M +160,000 New
Citigroup
36
Citigroup
New York
$2.96M -$1.19M -49,457 -26%
Allianz Asset Management
37
Allianz Asset Management
Germany
$2.66M +$499K +20,728 +20%
Swiss National Bank
38
Swiss National Bank
Switzerland
$2.22M +$166K +6,900 +7%
PAM
39
Panagora Asset Management
Massachusetts
$2.22M -$3.01M -125,003 -54%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$2.18M -$442K -18,360 -15%
JP Morgan Chase
41
JP Morgan Chase
New York
$2.11M -$182K -7,573 -7%
HF
42
HRT Financial
New York
$1.95M +$2.25M +93,308 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$1.89M +$725K +30,101 +50%
CM
44
Caption Management
Oklahoma
$1.89M +$18.1K +752 +0.8%
DCM
45
DAFNA Capital Management
California
$1.89M +$2.17M +90,000 New
Wells Fargo
46
Wells Fargo
California
$1.84M -$399K -16,583 -16%
Axa
47
Axa
France
$1.82M -$378K -15,700 -15%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.76M
PPA
49
Parametric Portfolio Associates
Washington
$1.72M -$61.6K -2,557 -3%
Ohio Public Employees Retirement System (OPERS)
50
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.7M

MGNX Hedge Fund Activity: Q3 2021 in Review

154 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2021, worth a combined $1.21B — down 21% from $1.53B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MGNX positions and 13 closed out — a net gain of 5 holders — while 43 added to existing stakes and 59 trimmed.

The largest buyer was RTW Investments, adding an estimated $34.4M. The largest seller was Holocene Advisors, exiting entirely with an estimated $40.3M sold.

  • 154 institutional investors held MacroGenics (MGNX) as of Q3 2021, up from 149 in Q2 2021.
  • Funds reported $1.21B of MacroGenics stock for Q3 2021, down 21% quarter-over-quarter.
  • 18 funds opened new MacroGenics positions in Q3 2021 and 13 closed out, a net change of +5 holders.
  • The largest MacroGenics buyer in Q3 2021 was RTW Investments, an estimated $34.4M added.
  • The largest MacroGenics seller in Q3 2021 was Holocene Advisors, an estimated $40.3M sold.

Based on aggregated 13F filings for Q3 2021.